Breast cancer can be divided into four molecular subtypes based on the expression of certain markers like estrogen receptor (ER), progesterone receptor (PR), and Human epidermal growth factor receptor 2 (HER2) while the subtype lacking the expression of all these receptors is known as triple-negative breast cancer (TNBC) (31). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.